Factors to Consider When Determining Whether Lipotoxicity Solely Causes B-Cell Decompensation in KPT2D [Letter]
Dan Geltser Imperial College London, School of Medicine, London, UKCorrespondence: Dan GeltserImperial College London, School of Medicine, London, UKEmail dg1116@ic.ac.uk I read with great interest the paper by Ye et al,1 which identified the significance of raised triglycerides in the trea...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/1f703038a51b4d8d91e8ea1a34355fe3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Dan Geltser Imperial College London, School of Medicine, London, UKCorrespondence: Dan GeltserImperial College London, School of Medicine, London, UKEmail dg1116@ic.ac.uk
I read with great interest the paper by Ye et al,1 which identified the significance of raised triglycerides in the treatment of ketosis-prone type 2 diabetes (KPT2D). The study concluded the need to implement lifestyle changes and administration of lipid-lowering medication for paediatric, hyperglycaemic KPT2D patients. As a 5th year medical student, who completed an intercalated BSc focusing on lipidology in diabetes mellitus, I would like to discuss further factors which should be considered when evaluating the conclusion.
View the original paper by Ye and colleagues |
|---|